TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Cancer Leadership Council letter calls for permanent leadership of NCI and FDA. November 23, 2005
TCL Archive CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued May 16, 1980
